MSH Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
MSH Capital Advisors's ABBV Position: Q3 2026 in Review
MSH Capital Advisors increased its AbbVie (ABBV) stake by 0.56% in Q3 2026, buying an estimated $25.6K and bringing the position to 17,914 shares worth $4.69M. The position accounts for 0.73% of the portfolio, ranked #31.
MSH Capital Advisors first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- MSH Capital Advisors held 17,914 shares of AbbVie worth $4.69M as of Q3 2026.
- MSH Capital Advisors bought 100 AbbVie shares in Q3 2026, an estimated $25.6K.
- AbbVie made up 0.73% of MSH Capital Advisors's portfolio in Q3 2026, its #31 holding.
- MSH Capital Advisors first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on MSH Capital Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.